New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|November 30, 2012
Supplements and Featured Publications
- A Novel Gastroretentive Formulation of Gabapentin for the Treatment of Postherpetic Neuralgia
A Novel Gastroretentive Formulation of Gabapentin for the Treatment of Postherpetic Neuralgia
Advertisement
Despite its efficacy for the treatment of postherpetic neuralgia, the potential benefits from treatment with gabapentin may be somewhat limited by its intrinsic properties. Gabapentin’s absorption characteristics—its active and saturable uptake within a narrow absorption window in the upper small intestine—pointed to the utility of a gastroretentive (GR) dosage form to improve the absorption of gabapentin at clinically relevant doses.
Information about the GR formulation of gabapentin is available in a recently released newsletter. To view the full newsletter, please click
Advertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Simple operational changes are proving more effective at closing gaps in cardiovascular-kidney-metabolic (CKM) syndrome care than education campaigns alone, according to panelists at at Population Health Roundtable
Panelists at AJMC roundtables in Philadelphia, Boston, Washington, DC, and Chicago traced why atopic dermatitis stays undertreated despite new therapies.
Eye care access for underserved patients with diabetes is limited and poorly understood. We identified barriers and innovative solutions to improve overall care and establish evidence-based practices.
Patient understanding should be treated as a measurable equity outcome, not an assumed byproduct of care.
The Right Care Initiative provides a proven, scalable framework for reducing preventable cardiovascular deaths. By integrating interorganizational learning, pharmacist-led care, and precision screening (coronary artery calcium imaging), the model bridges the 17-year implementation gap between clinical evidence and improved population health.
Advertisement
Advertisement
Trending on AJMC
1
Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD
2
Across the US, Obesity Care Still Lacks an Owner
3
FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes
4
Aspirin's CRC Benefit Narrows to PIK3CA Exon 9/20 Mutations
5